Stay updated on SKI-G-801 Dose Study in AML Clinical Trial

Sign up to get notified when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SKI-G-801 Dose Study in AML Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    1.0%
    Check dated 2025-04-30T13:43:45.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2025-04-23T08:15:48.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has undergone significant content removal, particularly details about a Phase 1 clinical trial for the drug SKI-G-801, including eligibility criteria and treatment protocols. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    26%
    Check dated 2025-04-16T01:35:21.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.5%
    Check dated 2025-04-08T19:57:55.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-03-25T04:45:19.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-03-10T20:51:46.000Z thumbnail image

Stay in the know with updates to SKI-G-801 Dose Study in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.